Jean-Baptiste Oudart Selected Research

Fibril-Associated Collagens (FACIT Collagen)

1/2016

The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Baptiste Oudart Research Topics

Disease

12	Neoplasms (Cancer) 12/2021 - 02/2015
5	Melanoma (Melanoma, Malignant) 01/2022 - 01/2016
4	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 01/2015
2	Communicable Diseases (Infectious Diseases) 10/2020 - 03/2015
2	Dementia (Dementias) 01/2020 - 01/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2019
2	Hypoxia (Hypoxemia) 01/2020 - 03/2011
2	Lung Neoplasms (Lung Cancer) 01/2019 - 06/2018
2	Rhabdomyosarcoma 01/2017 - 01/2016
1	Inflammation (Inflammations) 10/2020
1	Hemolysis 10/2020
1	Acidosis 01/2020
1	Cerebrospinal Fluid Leak 10/2017
1	Chronic Renal Insufficiency 09/2016
1	Hematologic Neoplasms (Hematological Malignancy) 03/2015
1	Paraproteinemias (Monoclonal Gammopathy) 03/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2015
1	Frontotemporal Dementia (Semantic Dementia) 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015
1	Hyperamylasemia 03/2011

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 10/2022 - 03/2011
6	CollagenIBA 12/2021 - 02/2015
4	Peptides (Polypeptides)IBA 12/2021 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2015
3	IntegrinsIBA 12/2021 - 01/2016
3	EnzymesIBA 01/2020 - 01/2015
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 12/2021 - 01/2018
2	tau Proteins (tau Protein)IBA 10/2017 - 01/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	HaptoglobinsIBA 10/2020
1	Hemoglobins (Hemoglobin)IBA 10/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2020
1	Collagen Type IV (Type IV Collagen)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Free RadicalsIBA 01/2020
1	LipidsIBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	ProteomeIBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 11/2016
1	homocitrullineIBA 09/2016
1	Cytidine Diphosphate (CDP)IBA 09/2016
1	Methotrexate (Mexate)FDA LinkGeneric 06/2016
1	Fibril-Associated Collagens (FACIT Collagen)IBA 01/2016
1	Biological ProductsIBA 03/2015
1	Blood Proteins (Serum Proteins)IBA 03/2015
1	Fibrinolysin FDA Link 02/2015
1	ImmunosorbentsIBA 01/2015
1	EndostatinsIBA 01/2015
1	Collagen Type XVIII (Type XVIII Collagen)IBA 01/2015
1	NAD (NADH)IBA 01/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2011
1	Amylases FDA Link 03/2011

Therapy/Procedure

2	Immunotherapy 01/2020 - 01/2019
1	Precision Medicine 06/2018
1	Drug Therapy (Chemotherapy) 06/2016